Last reviewed · How we verify

NCT06769399

Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis

Not yet recruiting Last updated 10 January 2025
What this trial tests

trial in Systemic Sclerosis (SSc) in 140 participants. Not yet recruiting.

Timeline
15 January 2025
Primary endpoint
15 April 2025
15 May 2025

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment140
Start date15 January 2025
Primary completion15 April 2025
Estimated completion15 May 2025

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 64, female only, with Systemic Sclerosis (SSc) or Sexual Dysfunctions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Systemic Sclerosis (SSc)

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06769399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing